Adenoviral vector: Began Phase I/II trial

Genetic Therapy Inc. (GTII), Gaithersburg, Md. Product: Adenoviral vector to deliver the cystic fibrosis transmembrane regulator gene Indication: Cystic fibrosis Status: Began Phase I/II trial in 15 p...